Evotec (ADR) (EVO)
Combines discovery, development and biologics manufacturing for pharmaceutical and biotechnology partners.
$1.58
After hours+0.01 (+0.64%)
At close$1.57(+1.95%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 0.91% | 3.24M ADS | |
|---|---|---|---|
| 35 holders · as of Jun 30, 2026 | |||
| Other | 99.09% | 352.00M ADS | |
| remainder | |||
355.24M ADS (1 ADS = 1 ordinary shares) as of Aug 31, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
The share count is from the company's Dec 2022 annual report; nothing newer is on file here.
13F, as of Jun 30, 2026
35 holders · 3.24M shares · 7 new positions · 18 increased · 7 reduced · 18 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| DCF Advisers, LLC | 1.08M | 0.30% | +13.8K | Aug 10, 2026 |
| WCM Investment Management, LLC | 671.9K | 0.19% | +44.6K | Aug 13, 2026 |
| Abc Arbitrage SA | 371.9K | 0.10% | −137.1K | Jul 20, 2026 |
| Optiver Holding B.V. | 322.2K | 0.09% | +38.6K | Aug 12, 2026 |
| Morgan Stanley | 205.8K | 0.06% | −54.0K | Aug 13, 2026 |
| LPL Financial LLC | 166.0K | 0.05% | +43.7K | Aug 7, 2026 |
| Envestnet Asset Management Inc | 139.6K | 0.04% | +20.2K | Aug 3, 2026 |
| Old Mission Capital LLC | 38.0K | 0.01% | +18.7K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Triton GP HoldCo SARLincl. Excalibur LuxCo SARL, Triton Fund 6 SCSp +2 more | 9.99% | 17.73M | 13D | Oct 29, 2025 |
| MAK Capital One L.L.C.incl. Michael A. Kaufman, MAK Capital Fund LP | 7.10% | 12.68M | 13D | May 1, 2026 |
Form 4
Latest trades
Nothing filed in the last 12 months.
House and Senate disclosures
Not reported.